Electrical and Echocardiographic Abnormalities during Viral Cirrhosis B

Aim: To describe electrical and echocardiographic abnormalities in patients with viral cirrhosis B. Methodology: Prospective cross-sectional study with an analytical aim carried out in the hospitalization and outpatient departments of the Hepato-Gastroenterology department and in the emergency department of the Cocody University Hospital during the period from January 15 to July 15, 2022. Any patient with viral B cirrhosis and having performed an echocardiography and an electrocardiogram was included. The significance threshold was stopped at p < 0.05 for these two statistical tests. Results: 40 patients were selected. The prevalence of viral B cirrhosis was 16.8% and that of cirrhotic cardiomyopathy in cirrhotic patients was 33.9%. The average age of the patients was 43.9 ± 14.1. There was a male predominance with a sex ratio of 3.4. The two main clinical signs found in patients were ascites (77.5%) and edema (75%). There was a lowering of TP (70%), albumin (72.5%) and platelets (87.5%). Bilirubin was elevated in 60% of patients. All patients had a liver with irregular contours. 80% of our population had not performed Fibroscan^？, 5% had fibrosis between F3-F4 and 35% F4 fibrosis. The main complication found was portal hypertension (esophageal varices at any stage) at 85%. Cirrhosis was active (virological) in 32.5% of patients. 75% of patients were classified as Child B. The two main abnormalities on echocardiography were left ventricular hypertrophy (32.5%) and dilatation of the left atrium (7.5%). The electrical abnormalities found were mainly QT prolongation (32.5%) and sinus tachycardia (12.5%). We did not find a statistically significant association between the severity of cirrhosis and electrical abnormalities. There was a statistically significant association between the severity of cirrhosis and the dilation of the left atrium (p = 0.04). Conclusion: Cirrhotic cardiomyopathy is a rare complication of cirrhosis.